The contribution of comorbidities to mortality in hospitalized patients with heart failure

Clinical Research in Cardiology

Volumn 107, Issue 6, 2018, Pages 487-497

  Riedel, Oliver ^a   Ohlmeier, C ^a,b   Enders, D ^a   Elsasser A ^c   Vizcaya, D ^d   Michel, A ^d   Eberhard, S ^e   Schlothauer, N ^f   Berg, J ^g   Garbe, E ^a  

^a LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^b IGES Institut GmbH   (Germany)

^c KLINIKUM OLDENBURG   (Germany)

^d BAYER AG   (Germany)

^e AOK Niedersachsen   (Germany)

^f Hausarztpraxis Dr Stephan Spiekermann Partner im Gesundheitszentrum   (Germany)

^g AOK Bremen Bremerhaven   (Germany)

Author keywords

Claims data; Comorbidities; Heart failure; Mortality

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ASTHMA; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; ELIXHAUSER COMORBIDITY INDEX; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MORTALITY RATE; OBESITY; PROPENSITY SCORE; RETROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; STABLE ANGINA PECTORIS; VALVULAR HEART DISEASE; VERY ELDERLY; ADOLESCENT; CHILD; ECHOCARDIOGRAPHY; FOLLOW UP; GERMANY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITAL PATIENT; INFANT; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; SURVIVAL RATE; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEART FAILURE; HUMANS; INFANT; INFANT, NEWBORN; INPATIENTS; MALE; MIDDLE AGED; PROGNOSIS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 85044919857     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-018-1210-x     Document Type: Article

References (39)

1. Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30–41
2. Zarrinkoub R, Wettermark B, Wandell P et al (2013) The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail 15:995–1002
3. Stork S, Handrock R, Jacob J et al (2017) Epidemiology of heart failure in Germany: a retrospective database study. Clin Res Cardiol 106:913–922
4. Stork S, Handrock R, Jacob J et al (2017) Treatment of chronic heart failure in Germany: a retrospective database study. Clin Res Cardiol 106:923–932
5. Brouwers FP, de Boer RA, van der Harst P et al (2013) Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 2013 34:1424–1431
6. Kannel W (2000) Incidence and epidemiology of heart failure. Heart Fail Rev 5:167–173
7. Lee GKM, Lee LC, Liu CWY et al (2010) Framingham risk score inadequately predicts cardiac risk in young patients presenting with a first myocardial infarction. Ann Acad Med Singap 39:163–167
8. Lam CSP, Donal E, Kraigher-Krainer E, Vasan RS (2011) Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 13:18–28
9. in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review. Eur J Heart Fail 18: 54–65
10. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259
11. Paulus WJ, van Ballegoij JJM (2010) Treatment of heart failure with normal ejection fraction an inconvenient truth! J Am Coll Cardiol 55:526–537
12. Somaratne JB, Berry C, McMurray JJV, Poppe KK, Doughty RN, Whalley GA (2009) The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. Eur J Heart Fail 11:855–862
13. Fonarow GC, Stough WG, Abraham WT et al (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure—a report from the OPTIMIZE-HF registry. J Am Coll Cardiol 50:768–777
14. Yancy CW, Lopatin M, Stevenson LW et al (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function—a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol 47:76–84
15. Dahlstrom U (2005) Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail 7:309–316
16. Rutten FH, Cramer MJM, Lammers JWJ, Grobbee DE, Hoes AW (2006) Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail 8:706–711
17. Hsich EM, Grau-Sepulveda MV, Hernandez AF et al (2012) Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. Am Heart J 163:430-U380
18. Jiang W, Alexander J, Christopher E et al (2001) Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161:1849–1856
19. Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271
20. Zile MR, Baicu CF, Gaasch WH (2004) Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. New Engl J Med 350:1953–1959
21. Zile MR, Gottdiener JS, Hetzel SJ et al (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124:2491–2501
22. Massie BM, Carson PE, McMurray JJ et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. New Engl J Med 359:2456–2467
23. Solomon SD, Claggett B, Lewis EF et al (2016) Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J 37:455–462
24. Parsons L (2001) Reducing bias in a propensity score matched-pair sample using greedy matching techniques. SUGI26. Paper 214–26
25. Chiang C (1967) Standard error of the age-adjusted death rate. Vital Statistics—Special Reports, Selected Studies 47
26. Mentz RJ, Kelly JP, von Lueder TG et al (2014) Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 64:2281–2293
27. Hogg K, Swedberg K, McMurray J (2004) Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43:317–327
28. Centres for Medicare & Medicaid Services (2012) Chronic conditions among medicare benificiaries—Chartboo, 2012 Edition. Centes for Medicare & Medicaid Services, Baltimore
29. Tschope C, Birner C, Bohm M et al (2018) Heart failure with preserved ejection fraction: current management and future strategies. Clin Res Cardiol 107:1–19
30. van Deursen VM, Urso R, Laroche C et al (2014) Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 16:103–111
31. Ruigomez A, Michel A, Martin-Perez M, Rodriguez LAG (2016) Heart failure hospitalization: an important prognostic factor for heart failure re-admission and mortality. Int J Cardiol 220:855–861
32. Ather S, Chan W, Bozkurt B et al (2012) Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59:998–1005
33. Felker GM, Shaw LK, Stough WG, O’Connor CM (2006) Anemia in patients with heart failure and preserved systolic function. Am Heart J 151:457–462
34. MacDonald MR, Petrie MC, Varyani F et al (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure. Eur Heart J 29:1377–1385
35. Smith DH, Thorp ML, Gurwitz JH et al (2013) Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction the cardiovascular research network PRESERVE study. Circ Cardiovasc Qual Outcomes 6:333–342
36. Lupon J, Diez-Lopez C, de Antonio M et al (2017) Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Eur J Heart Fail 19:1615–1623
37. Chang HJ, Chen PC, Yang CC, Su YC, Lee CC (2016) Comparison of Elixhauser and Charlson methods for predicting oral cancer survival. Medicine 95
38. Li B, Evans D, Faris P, Dean S, Quan H (2008) Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res 8
39. Sharabiani MTA, Aylin P, Bottle A (2012) Systematic review of comorbidity indices for administrative data. Med Care 50:1109–1118